RxDoctor Payments Data

Stuart Green

Los Alamitos, CANPI 1881702504

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,125,132 of the $1,325,112 with a category attached, or 84.9%. Nuvasive Specialized Orthopedics, Inc. accounts for 65.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $323,760 and has fallen 84.2% since, to $51,315 in 2025.

$1,325,112in general payments, 2019–2025

Across 111 payments — averaging $11,938 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nuvasive Specialized Orthopedics, Inc.$870K
  • Smith+Nephew$362K
  • Globus Medical$93K
  • Medical Device Business Services, Inc.$136
  • Bioventus LLC$99
  • Radius Health, Inc.$62
  • plus $16 from 1 others

What the payments were for

  • Royalty or licence$1,125,13285%
  • Consulting fees$191,13814%
  • Travel & lodging$3,4980%
  • Food & beverage$5,3090%
  • Education$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →